Výsledky vyhledávání - "Douglas Foerster"

Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey

Autor: Jordi Díaz-Manera, J. Andoni Urtizberea, Carina Schey, Anna Kole, Philipp von Gallwitz, Amy Whiting, Douglas Foerster, Alla Zozulya-Weidenfeller

Publikováno v: Neuromuscular Disorders. 33:208-217

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f888ccd174648b93ac3624cfa26cb80b
https://doi.org/10.1016/j.nmd.2022.12.008

Zobrazit plný text záznamu

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

Autor: Sebastian Braun, Elmira Lechat, Jürgen Stein, Douglas Foerster, Kerry Nip, Daniel C. Baumgart, S.H. Ong, Jennifer S. Haas, Thomas Hardt, K. Borchert

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Jürgen Stein,1,2 Jennifer Scarlet Haas,3 Siew Hwa Ong,4 Kathrin Borchert,3 Thomas Hardt,5 Elmira Lechat,4 Kerry Nip,5 Douglas Foerster,4 Sebastian Braun,3 Daniel C Baumgart6 1Interdisciplinary Crohn Colitis Center Rhein-Main, Frankfurt/Main, Germany

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb01c88414cfc98888019c7f9019c52f
https://doi.org/10.2147/ceor.s150900

Zobrazit plný text záznamu

The changing role of economic evaluation in valuing medical technologies

Autor: Jason S Rotter, Douglas Foerster, John F.P. Bridges

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research. 12:711-723

Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The chang

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbed5d77ee6722b59e18e67d9e060d83
https://doi.org/10.1586/erp.12.73

Zobrazit plný text záznamu

Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model

Autor: Rick Aultman, Douglas Foerster, Ute Zerwes, Tamlyn Rautenberg

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Background The safety and efficacy of racecadotril to treat acute watery diarrhea (AWD) in children is well established, however its cost effectiveness for infants and children in Europe has not yet been determined. Objective To evaluate the cost uti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6686f42bbe447cc0c7d9d3cb1ea861
http://europepmc.org/articles/PMC3345933

Zobrazit plný text záznamu

Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life

Autor: Helmut Friess, York Zöllner, Güralp O. Ceyhan, Jan G. D’Haese, Birgit Gradl, Reinhard Rychlik, Ihsan Ekin Demir, Friederike Henniges, Douglas Foerster, Peter Layer, Matthias Löhr, Waldemar Uhl, Julia Möbius, Konstantinos T. Pirilis

Publikováno v: Pancreas. 43(6)

OBJECTIVE: Exocrine pancreatic insufficiency (EPI) is frequent in patients with chronic pancreatitis (CP). This 1-year, prospective, multicenter, observational, disease management study aimed to assess symptom improvement and quality of life in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f533845024ccbec1124717985a9e26
https://pubmed.ncbi.nlm.nih.gov/24717829

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání